Search
for
Sort by
Research 421–450 of 1000+
- Disorders of hair growth and the pilosebaceous unit: Facts and controversies
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Personalized scalp and hair care. Overview of trichological products and therapies
- Nanotechnology in Cosmetics: An Overview
- Herbal Nanocosmeceuticals: The Ultimate Fusion of Science and Nature
- GPX4 mRNA levels in the PMNs are negatively correlated with autoantibody production, disease activity and lupus alopecia in SLE
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- HDL as Therapeutic Tools
- Role of Non Androgenic Factors in Hair loss and Hair Regrowth
- Dermatological Benefits of Cosmetics
- The diagnosis and management of alopecia
- SUMMARIES OF PAPERS
- 10.51847/ubmwCM2
- Interrelation of immunity and tissue repair or regeneration
- Antiglicants
- 5α-Reduced glucocorticoids: a story of natural selection
- Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
- Lupus erythematosus: systemic and cutaneous manifestations
- Hormonal contraceptives: pharmacology tailored to women's health
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Mushroom Cosmetics: The Present and Future
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- The Facial Adipose Tissue: A Revision
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata